CC
KROS icon

Casdin Capital’s Keros Therapeutics KROS Stock Holding History

Casdin Capital’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65,000
Closed -$3.12M – 43
2022
Q4 		$3.12M Buy
+65,000
New +$3.12M 0.24% 39